Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial

INTRODUCTION: The objective of this study was to assess the impact of certolizumab pegol (CZP) treatment on health-related quality of life (HRQoL), fatigue and other patient-reported outcomes (PROs) in patients with rheumatoid arthritis (RA). METHODS: Patients with active RA (N = 982) were randomize...

Descripción completa

Detalles Bibliográficos
Autores principales: Strand, Vibeke, Mease, Philip, Burmester, Gerd R, Nikaï, Enkeleida, Coteur, Geoffroy, van Vollenhoven, Ronald, Combe, Bernard, Keystone, Edward C, Kavanaugh, Arthur
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003523/
https://www.ncbi.nlm.nih.gov/pubmed/19909548
http://dx.doi.org/10.1186/ar2859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003523/
https://www.ncbi.nlm.nih.gov/pubmed/19909548
http://dx.doi.org/10.1186/ar2859

Ejemplares similares